Pharmaceutical products

Tender description

NHS national framework agreement for the supply of generic pharmaceuticals — Interim 1 2020. Offer reference number: CM/PHG/20/5589 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the authority's sole discretion) for up to a further 12 months). Potential periods of call-offs under the framework agreement Hospital Only Products: DLS/DNE/DNW 1 August 2020 to 31 July 2021 (12 months), DLN/DCE/DSW 1 August 2020 to 31 July 2021 (12 months). Products on the framework include (but are not limited to): — Darunavir — Disodium Pamidronate — Doxorubicin — Epirubicin — Ethambutol — Etoposide — Glycopyrronium Bromide — Ibuprofen — Irinotecan — Lopinavir/Ritonavir — Milrinone — Posaconazole — Ritonavir — Salbutamol — Tramadol — Vancomycin. Details of presentation sizes and volumes are within the tender document set. NHS national framework agreement for the supply of generic pharmaceuticals — Interim 1 2020. Offer reference number: CM/PHG/20/5589 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the authority's sole discretion) for up to a further 12 months). Potential periods of call-offs under the framework agreement: 1 August 2020 to 31 July 2021. NHS national framework agreement for the supply of generic pharmaceuticals — Interim 1 2020. Offer reference number: CM/PHG/20/5589 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the authority's sole discretion) for up to a further 12 months). Potential periods of call-offs under the framework agreement. 1 August 2020 to 31 July 2021.